KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.45% | 24.22% | 5.24% | -2.83% | 8.01% |
| Total Depreciation and Amortization | 9.84% | 3.03% | -1.43% | -20.25% | -20.78% |
| Total Amortization of Deferred Charges | -45.08% | -40.38% | -4.17% | 4.21% | 3.96% |
| Total Other Non-Cash Items | 22.15% | -7.98% | -20.05% | 172.16% | 21.19% |
| Change in Net Operating Assets | 133.89% | -24.73% | 147.18% | -85.54% | -370.18% |
| Cash from Operations | 16.07% | 18.63% | 40.25% | -60.06% | -21.33% |
| Capital Expenditure | 55.56% | -- | -885.71% | 67.97% | 83.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 55.56% | -- | -885.71% | -100.93% | 99.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -38.10% | 1,947.89% | -- | 387.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -0.84% | -- | -- | -- |
| Cash from Financing | -116.90% | -101.60% | 162.17% | -550.00% | 387.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -279.75% | -270.67% | 138.29% | -173.38% | 139.29% |